Childhood Cancer

You are here

Home » Grants » All grants tagged with "Glioma"

All grants tagged with "Glioma"

Reversing Feedback Immunosuppression during Oncolytic Virotherapy of Pediatric High Grade Glioma
Bangxing Hong, PhD
Augusta University Research Institute, Inc.
Reach Grants, Awarded 2023
The Interplay Between Histone Mutations and Replication Stress in Shaping Glioma Phenotypes
Pratiti Bandopadhayay, PhD
Dana-Farber Cancer Institute
'A' Award Grants, Awarded 2021
Role of H3.3-G34R mutation in pediatric high-grade glioma
Jian Hu, PhD
University of Texas M.D. Anderson Cancer Center
Innovation Grants, Awarded 2021
Dissecting the Role of FOXR2 in the Oncogenesis of Diffuse Intrinsic Pontine Glioma
Jessica Tsai, MD/PhD
Dana-Farber Cancer Institute
Young Investigator Grants, Awarded 2020
Using Neurofibromatosis-1 (NF1) to understand Pediatric Brain Tumor Initiation
Yuan Pan, PhD
MD Anderson Cancer Center
Young Investigator Grants, Awarded 2020
Identifying Epistatic Suppressors of Oncohistone in Pediatric High-Grade Gliomas
Carol Chen, PhD
BC Cancer (Provincial Health Services Authority)
Young Investigator Grants, Awarded 2020
Single Cell RNA Sequencing of Pediatric High- and Low-Grade Gliomas
Adam Green, MD and Jean Mulcahy Levy, MD
University of Colorado Denver
Single-cell Pediatric Cancer Atlas Grant, Awarded 2019
Elucidating the Role of SETD2 in Pediatric High Grade Glioma Formation
Thomas De Raedt, PhD
Children’s Hospital of Philadelphia
'A' Award Grants, Awarded 2019
Exploiting the Differentiation Potential of Pediatric High-Grade Glioma to Discover Novel Therapeutic Opportunities
Mariella Filbin, MD/PhD
Dana-Farber Cancer Institute
'A' Award Grants, Awarded 2019
The use of hematopoietic stem and progenitor cells to reverse treatment resistance to PD-1 blockade
Catherine Flores, PhD
University of Florida
Innovation Grants, Awarded 2019

Pages

All childhood cancer types

Featured Hero

Seth Walsh

Seth is spunky and can be friends with anyone. After being diagnosed with ALL, Seth endured countless trips out-of-state, four relapses, two CAR T-cell therapies, two bone marrow transplants, and one clinical trial. Today, Seth has reached remission!
Read more »